Study of the “in vitro” gastrointestinal resistance of a symbiont and its intestinal microbiota modulation capacity

To verify the efficacy of our symbiont, Derbós together with the AINIA Technology Centre, has developed a study on the “in vitro” gastrointestinal resistance of our symbiotic supplement and its ability to modulate the microbiota.


The results of this study, performed in an artificial stomach, show that daily intake of this symbiont has a notable influence on human flora, causing an increase in those microbial groups having a beneficial effect on health, compared to other fecal microbiota.